HRS late-breaking data: Interim results highlight six-month outcomes for patients treated with the Sphere-9 catheter for sustained monomorphic ventricular tachycardia (VT) Breakthrough device designation granted for use of the Sphere-9 catheter for treatment of VT; U.S. pivotal trial...
Hence then, the article about medtronic announces key affera clinical study milestones for sphere 9 and sphere 360 catheters as global adoption continues was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Medtronic announces key Affera™ clinical study milestones for Sphere-9™ and Sphere-360™ catheters as global adoption continues )
Also on site :
- The Newest 'Fun Ship' in the World Just Picked a Surprising U.S. Homeport
- Most Australian teens admit the social media ban isn’t working as they try to sidestep age verification blocks with face masks and their parents’ IDs
- Ann-Margret Is About to Turn 85—Her Birthday Plans Might Surprise You (Exclusive)